The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading ->
Six schoolchildren in the Ugandan capital of Kampala are the latest to be infected with Ebola, according to the country’s health minister on Wednesday – and with 15 cases in the densely populated city, some want the government to impose a lockdown. So far, there have been 109 confirmed cases, including 30 deaths, of the […] Continue reading ->
China administered the world’s first oral aerosol COVID-19 vaccine boosters in Shanghai on Wednesday, as new lockdown measures were imposed on Wuhan, the supposed birthplace of the pandemic. Chinese vaccine manufacturer CanSino Biologics said in a media statement that the inclusion of its vaccine in Shanghai’s booster vaccination program marked “the start of the rollout […] Continue reading ->
Most countries are failing dismally to promote physical exercise despite inactivity playing a major role in heart disease, obesity and diabetes, according to the World Health Organization (WHO). The WHO’s newly released Global status report on physical activity 2022 measures the extent to which governments are implementing recommendations to increase physical activity across all ages […] Continue reading ->
With more cholera outbreaks overstretching the world’s limited vaccine supply, WHO recommends temporarily suspending the standard two-dose regimen to vaccinate more people. Meanwhile, Africa aims to re-energize its COVID-19 vaccine rollout, despite steady decline in public turnout for vaccination.  A shortage in the global supply of cholera vaccines has forced the World Health Organization to […] Continue reading ->
A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading ->